the firm's post-grant practitioners are some of the most experienced in the country.


Artificial Intelligence (AI)
Artificial Intelligence (AI)
Digital Health
Digital Health
Energy & Renewables
Energy & Renewables

Fast Facts

About Our

Law Firm

About Our Law Firm

Headquartered within steps of the USPTO with an affiliate office in Tokyo, Oblon is one of the largest law firms in the United States focused exclusively on intellectual property law.

Get to know our


Get to know our History

Norman Oblon with Stanley Fisher and Marvin Spivak launched what was to become Oblon, McClelland, Maier & Neustadt, LLP, one of the nation's leading full-service intellectual property law firms.

Our Local and

Global Reach

Our Local and Global Reach

Outside the US, we service companies based in Japan, France, Germany, Italy, Saudi Arabia, and farther corners of the world. Our culturally aware attorneys speak many languages, including Japanese, French, German, Mandarin, Korean, Russian, Arabic, Farsi, Chinese.

A few of our


A few of our ACCOLADES

Oblon's professionals provide industry-leading IP legal services to many of the world's most admired innovators and brands.




From the minute you walk through our doors, you'll become a valuable part of a team that fosters a culture of innovation, client service and collegiality.

A few ways to

GET In Touch

A few ways to GET In Touch
US Office

Telephone: 703-413-3000
Learn More +

Tokyo Office

Telephone: +81-3-6212-0550
Learn More +


Patent Forms

Downloadable Patent Forms

The United States Patent and Trademark Office (USPTO) issued final rules implementing the inventor's oath or declaration provisions of the America Invents Act (AIA) on August 14, 2012.

Stay informed with

Our Blogs

USPTO Announces Updates to Rules for Applications including Nucleotide and Amino Acid Sequences, effective July 1, 2024

  • May 3, 2024
  • Firm News

A final ruling has been issued by the U.S. Patent and Trademark Office (USPTO) regarding applications which contain nucleotide and/or amino acid sequences. The changes are made to reflect the adoption of version 1.7 of the Standard ST.26 of the World Intellectual Property Organization (WIPO).  In 2022, the USPTO initially incorporated by reference certain provisions of the WIPO Standard ST.26.

ST.26 simplifies the process for applicants filing in multiple countries and requires the submission of single-sequence listings in eXtensible Markup Language (XML), which provides better preservation, accessibility, and sorting of the submitted sequence data for the public. Updated improvements provided by version 1.7 of ST.26 include technical terminology consistency and improved descriptions.

This final ruling will be effective on Monday, July 1, 2024 and can be found here and on the USPTO webpage.